Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy

ClinicoEconomics and Outcomes Research · Published 2026-06-01 · DOI 10.2147/ceor.s599644

Free full text

Authors (8)

Gianni Ghetti, Luca Castello, Linet Odonde, Serena De Fazio, Andrea Stella, Angela Bruno, Emanuele Marchionne, Massimiliano Bonifacio

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Ghetti, G., Castello, L., Odonde, L., et al. (2026). Cost-Effectiveness of Blinatumomab Plus Chemotherapy vs Chemotherapy in Adults Newly Diagnosed with Philadelphia-Negative B-Cell Acute Lymphoblastic Leukemia in Italy. ClinicoEconomics and Outcomes Research. https://doi.org/10.2147/ceor.s599644

Related articles

• Economic Burden of Overall and Advanced Light Chain Amyloidosis: Results from a Claims Linked Electronic Health Record Database Analysis · ClinicoEconomics and Outcomes Research · 2026 · Same journal
• Retrospective Study of Real-World Treatment Patterns of Subcutaneous Semaglutide Use Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in the United States · ClinicoEconomics and Outcomes Research · 2025 · Same journal
• Cost-Effectiveness Analysis and Priority Setting in the Transition from Iron-Folic Acid (IFA) to Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Indonesia · ClinicoEconomics and Outcomes Research · 2025 · Same journal
• Economic Evaluation of Extended-Release Amphetamine (Dyanavel XR) Among Individuals with Attention-Deficit/Hyperactivity Disorder From a United States Societal Perspective · ClinicoEconomics and Outcomes Research · 2025 · Same journal
• Characteristics and Utilization Patterns of Medicare Beneficiaries Initiating Long-Acting Injectable Antipsychotic Medications · ClinicoEconomics and Outcomes Research · 2026 · Same journal
• Cost-Utility Analysis of Renal Replacement Therapy Modalities in the Management of Severe Acute Kidney Injury in US Critically Ill Patients · ClinicoEconomics and Outcomes Research · 2025 · Same journal
• Retrospective Database Analysis of the Clinical and Economic Outcomes Associated with Disruptive Surgical Bleeding · ClinicoEconomics and Outcomes Research · 2025 · Same journal
• Socio-Economic Impacts of Childhood Sickle Cell Disease on Households in Lubumbashi: An Exploratory Mixed-Methods Study · ClinicoEconomics and Outcomes Research · 2026 · Same journal
• Early Health Technology Assessment (HTA) of Olpasiran and Pelacarsen for Secondary Prevention of Coronary Heart Disease (CHD) · ClinicoEconomics and Outcomes Research · 2026 · Same journal
• Analysis of Cost-Effectiveness of Biologic Therapies in Axial Spondyloarthritis Based on Real-World Data · ClinicoEconomics and Outcomes Research · 2025 · Same journal